| View |
|
DR-XY48542
|
Sitagliptin (as phosphate monohydrate)
|
Sitamac 25
|
25 mg
|
Film-Coated Tablet
|
-
|
Macleods Pharmaceuticals Limited
|
India
|
Initial
|
03 January 2023
|
03 January 2028
|
| View |
|
DR-XY48543
|
Sitagliptin (as phosphate monohydrate)
|
Sitamac 50
|
50 mg
|
Film-Coated Tablet
|
-
|
Macleods Pharmaceuticals Limited
|
India
|
Initial
|
03 January 2023
|
03 January 2028
|
| View |
|
DR-XY48544
|
Sitagliptin (as phosphate monohydrate)
|
Sitamac 100
|
100 mg
|
Film-Coated Tablet
|
-
|
Macleods Pharmaceuticals Limited
|
India
|
Initial
|
03 January 2023
|
03 January 2028
|
| View |
|
DR-XY48553
|
Sitagliptin (as phosphate monohydrate) + Metformin
Hydrochloride
|
Sitamac M 50/1000
|
50 mg/1 g
|
Film-Coated Tablet
|
-
|
Macleods Pharmaceuticals Limited
|
India
|
Initial
|
05 January 2023
|
05 January 2028
|
| View |
|
DR-XY48552
|
Sitagliptin (as phosphate monohydrate) + Metformin
Hydrochloride
|
Sitamac M 50/500
|
50 mg / 500 mg
|
Film-Coated Tablet
|
-
|
Macleods Pharmaceuticals Limited
|
India
|
Initial
|
05 January 2023
|
05 January 2028
|
| View |
|
DRP-13258
|
Norepinephrine (as bitartrate monohydrate)
|
Norfion
|
1 mg/mL (4 mg/ 4 mL)
|
Concentrate Solution for Injection for I.V. Infusion
|
-
|
PT. Bernofarm
|
Indonesia
|
Initial (Re-application)
|
11 January 2023
|
11 January 2028
|
| View |
|
DRP-13210
|
Rivaroxaban
|
Riroxaban 10
|
10 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
03 January 2023
|
03 January 2028
|
| View |
|
DRP-13212
|
Rivaroxaban
|
Riroxaban 20
|
20 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
03 January 2023
|
03 January 2028
|
| View |
|
DRP-13211
|
Rivaroxaban
|
Riroxaban 15
|
15 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
03 January 2023
|
03 January 2028
|
| View |
|
DRP-13229
|
Sitagliptin (as Phosphate monohydrate) + Metformin Hydrochloride
|
Gliforge
|
50mg/500mg
|
Film-coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
05 January 2023
|
05 January 2028
|
| View |
|
DRP-13230
|
Sitagliptin (as phosphate monohydrate) + Metformin
Hydrochloride
|
Gliforge
|
100mg/1 g
|
Film-coated Tablet
|
-
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
05 January 2023
|
05 January 2028
|
| View |
|
DR-XY48557
|
Sevelamer Carbonate
|
Cavsamir
|
800 mg
|
Film-Coated Tablet
|
-
|
Dr. Reddy's Laboratories Limited
|
India
|
Initial
|
06 January 2023
|
06 January 2028
|
| View |
|
DRHR-2193
|
Ethyl Alcohol
|
AlcoPlus
|
70% (v/v)
|
Solution
|
-
|
Cianan Corp.
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
HRP-559
|
Cebo De Macho
|
None
|
97% (w/w)
|
Ointment
|
-
|
Greatstar Laboratories
|
Philippines
|
Initial
|
12 January 2023
|
12 January 2025
|
| View |
|
DRHR-2189
|
Ethyl Alcohol
|
None
|
70% (v/v)
|
Solution
|
-
|
Am-Europharma Corporation
|
Philippines
|
Initial
|
11 January 2023
|
11 January 2028
|
| View |
|
DRHR-2186
|
Ethyl Alcohol
|
Cristin
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRHR-2185
|
Ethyl Alcohol
|
Nathan
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRHR-2190
|
Ethyl Alcohol
|
Nathan
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRHR-2191
|
Isopropyl Alcohol
|
Amiel
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRHR-2184
|
Isopropyl Alcohol
|
Amiel
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|